Back to today’s briefing

Story perspectives

Helaina's Lactoferrin Innovation Set to Transform Women's Health

7/22/2025

38 3

Summary

Story summary

New York's Helaina is revolutionizing women's health with its precision-fermented human lactoferrin, effera, now produced in metric tons—enough for 10 million servings per batch. This innovative approach aims to replace bovine lactoferrin, promoting better gut health and immunity. With $83 million in funding, Helaina is poised to make a significant impact.

1 of 1

Story summary

New York's Helaina is revolutionizing women's health with its precision-fermented human lactoferrin, effera, now produced in metric tons—enough for 10 million servings per batch. This innovative approach aims to replace bovine lactoferrin, promoting better gut health and immunity. With $83 million in funding, Helaina is poised to make a significant impact.